Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Integra LifeSciences Corporation
WARNING LETTER
•Integra LifeSciences Corporation•August 25, 2011

Integra LifeSciences Corporation – FDA Warning Letter, Aug 25, 2011

Record Details

On July 22, 2011, an FDA inspection of Integra LifeSciences Corporation in Plainsboro, New Jersey, revealed significant violations of the Quality System (QS) regulation (21 CFR Part 820) for medical devices, including Duragen XS Dural Regeneration Matrix and Integra Artificial Skin. The devices were deemed adulterated under section 501(h) of the Act.

Key violations include: 1. **Environmental Control (21 CFR 820.70(c)):** Failure to control environmental conditions, specifically persistent mold contamination in manufacturing areas since June 2009, despite a third-party report indicating product integrity risk. The firm continued manufacturing approximately (b)(4) lots. Inadequate and ambiguous re-sampling procedures for Out of Specification (OOS) results were also cited, along with unperformed HEPA filter velocity verifications. 2. **Process Validation (21 CFR 820.75(a)):** Inadequate cleaning validation for manufacturing tanks, lacking a (b)(4) coverage test, and continued use of unvalidated equipment. The WFI Distribution System's TOC and conductivity sensor validation lacked a Performance Qualification (PQ), and data from an unvalidated recorder was used to release quarantined products. 3. **Nonconforming Product Control (21 CFR 820.90(a)):** Failure to adequately investigate nonconforming products, including

Company
Integra LifeSciences Corporation
Inspection date
August 25, 2011
Product type
Devices
Office
New Jersey District Office
Person
  • Diana Amador-Toro (District Director)
View Company Profile

ID · f1658a49-ec81-443f-9fba-76c0174635e8

Violation Codes6
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 803.50(a)(2)21 U.S.C. 352(t)(2)21 U.S.C. 360i

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Integra LifeSciences Corporation
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.